triazoles has been researched along with Fungemia in 116 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (3.45) | 18.2507 |
2000's | 67 (57.76) | 29.6817 |
2010's | 44 (37.93) | 24.3611 |
2020's | 1 (0.86) | 2.80 |
Authors | Studies |
---|---|
Moncada, D; Ramírez, I | 1 |
Bertaccini, P; Castagnetti, F; Cavo, M; Faccioli, L; Lewis, RE; Paolucci, M; Primavera, L; Rizzello, I; Spinardi, L; Stanzani, M; Toschi, PG | 1 |
Al-Hatmi, AM; Arastehfar, A; Bakhtiari, M; Boekhout, T; Daneshnia, F; Fang, W; Groenewald, M; Hagen, F; Liao, W; Pan, W; Sadati, SK; Sharifi-Mehr, H; Zomorodian, K | 1 |
Gao, Y; Ping, B; Wu, B; Yue, C; Zhu, Y | 1 |
De la Serna, J; Fernández-Navarro, JM; Gómez, V; Jarque, I; Jurado, M; López-Jiménez, J; Pascual, A; Romero, M; Serrano, J; Vallejo, C | 1 |
Bertz, H; Drognitz, K; Lübbert, M | 1 |
Böhme, A; Buchheidt, D; Cornely, OA; Egerer, G; Heinz, W; Krüger, W; Link, H; Maschmeyer, G; Mousset, S; Neumann, S; Ostermann, H; Panse, J; Penack, O; Rieger, C; Ruhnke, M; Schmidt-Hieber, M; Silling, G; Südhoff, T; Ullmann, AJ; Wolf, HH | 1 |
Adamski, Z; Gil, L; Komarnicki, M; Kubisiak-Michalska, A; Kubisiak-Rzepczyk, H; Mol, A; Reich, A; Zawirska, A | 1 |
Atalay, MA; Copur Çiçek, A; Kasap Tekinşen, FF; Kaynar, L; Koç, AN; Sav, H | 1 |
Costantino, F; Di Biasi, C; di Coste, A; Duse, M; Ernesti, I; Melengu, T; Savastano, V; Schiavi, L; Tarani, L | 1 |
Cuenca-Estrella, M; Escribano, P; Guinea, J; Martín-Mazuelos, E; Pemán, J; Sánchez-Reus, F; Zaragoza, Ó | 1 |
Choudhury, S; Marte, RL | 1 |
Boekhout, T; Doroftei, B; Flonta, MM; Kolecka, A; Lupse, M; Man, A; Marangoci, N; Mares, M; Marincu, I; Minea, B; Moraru, RF; Nastasa, V; Pinteala, M; Toma, F | 1 |
Borlenghi, E; Caimi, L; Cattaneo, C; Lamorgese, C; Panzali, A; Passi, A; Petullà, M; Re, A; Rossi, G | 1 |
Cranswick, N; Curtis, N; Gwee, A | 1 |
Arilla, MJ; Boluda, B; Calvillo, P; Cano, I; Carpio, N; Jarque, I; Lancharro, A; López-Chuliá, F; Lorenzo, I; Martínez, J; Martínez-Cuadrón, D; Montesinos, P; Navarro, I; Pemán, J; Rodríguez-Veiga, R; Salavert, M; Sanz, GF; Sanz, J; Sanz, MA | 1 |
Candoni, A; Chandrasekar, P; Connelly, N; Cornely, OA; Duarte, RF; Haider, S; Helfgott, D; Jiménez, JL; Kartsonis, N; Langston, A; Laverdiere, M; Raad, I; Van Iersel, M; Waskin, H | 1 |
Alem, N; Karabıçak, N | 1 |
Bosch, M; Cantón, E; Espinel-Ingroff, A; Gobernado, M; Pemán, J; Valentín, A | 1 |
Coombs, C; Cottrill, E; Gonis, G; Trotter, DJ | 1 |
Cleveland, KO; Lacasse, A | 1 |
Alastruey-Izquierdo, A; Araujo Ribeiro, M; Cuenca-Estrella, M; Gomez-Lopez, A; Rodriguez-Tudela, JL | 1 |
Almirante, B; Pemán, J | 1 |
Kisac, P; Krcmery, V; Liskova, A | 1 |
Azuma, E; Hosoki, K; Iwamoto, S; Komada, Y; Kumamoto, T | 1 |
Auberger, J; Bellmann, R; Bellmann-Weiler, R; Joannidis, M; Lass-Flörl, C; Stein, M; Weiler, S | 1 |
Chakrabarti, A; Chatterjee, SS; Rao, KL; Shivaprakash, MR; Singh, R; Singhi, S; Varma, SC; Zameer, MM | 1 |
Jadoul, M; Labriola, L; Swinne, D; V, B | 1 |
Fanci, R | 1 |
Joshi, A; Khattry, N; Shah, MS; Singh, R; Umesh, S | 1 |
Amorim, CS; Briones, MR; Colombo, AL; Gonçalves, SS; Melo, AS; Nucci, M; Padovan, AC | 1 |
Akova, M; Beyazit, Y; Purnak, T; Sahin, GO; Shorbagi, A | 1 |
Bonnal, C; Bouges-Michel, C; Bretagne, S; Chochillon, C; Dannaoui, E; Datry, A; Develoux, M; Dromer, F; Matheron, J; Paugam, A | 1 |
Graninger, W; Kratzer, C; Lassnigg, A; Presterl, E; Tobudic, S | 1 |
Almela, M; Marco, F; Martínez, JA; Mensa, J; Ortega, M; Pitart, C; Soriano, A | 1 |
Furuya, A; Ida, K; Kato, M; Koh, K; Okamoto, T; Takita, J | 1 |
Bouchara, JP; Chabasse, D; Hitoto, H; Pihet, M; Rachieru-Sourisseau, P; Weil, B | 1 |
Segal, BH; Sherif, R | 1 |
Gabrielian, A; Hariprasad, SM | 1 |
Falzone, E; Guarneri, L; Gugliara, C; Maffeo, F; Pasqua, P; Pulvirenti, F | 1 |
Accoceberry, I; Gabriel, F; Noel, T | 1 |
Ciecko, SC; Scher, R | 1 |
Chang, FY; Ho, SJ; Lin, JC; Shang, ST; Wang, NC; Yang, YS | 1 |
Ruiz-Camps, I | 1 |
Garcia-Hermoso, D; Gay-Andrieu, F; Haloun, A; Le Pape, P; Leclair, F; Lepoivre, T; Miegeville, M; Miossec, C; Morio, F; Treilhaud, M | 1 |
Chugh, TD; Duggal, S; Jain, H; Sharma, A; Tyagi, A | 1 |
Doroftei, B; Mareş, M; Năstasă, V; Ramona, FM; Stefanache, A | 1 |
Hamoud, S; Hayek, T; Keidar, Z | 1 |
Demitrovicova, A; Kisac, P; Krcmery, V | 1 |
Bedini, A; Cavrini, F; Cocchi, S; Codeluppi, M; De Ruvo, N; Di Benedetto, F; Gennari, W; Gerunda, GE; Grottola, A; Guaraldi, G; Rumpianesi, F; Venturelli, C | 1 |
Hayashi, T; Hosokawa, K; Ishiyama, K; Kondo, Y; Mochizuki, K; Nakao, S; Ohata, K; Okumura, H; Sugimori, N; Takami, A; Yamazaki, H | 1 |
Catania, MR; De Domenico, G; Panellis, D; Pulcrano, G; Rossano, F | 1 |
Cleveland, KO; Gelfand, MS; Rao, V | 1 |
Maack, KH; Tarp, B | 1 |
Bell, W; Chaaban, MR; Woodworth, BA | 1 |
Brisou, P; Darles, C; Gaillard, T; Pons, S; Roméo, E | 1 |
Danielsen, R; Einarsdóttir, HM; Gottfredsson, M | 1 |
Howden, BP; Mijch, AM; Schwarer, AP; Slavin, MA | 1 |
Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA; Tendolkar, S | 1 |
Almela, M; Danés, C; de la Bellacasa, JP; Espasa, M; Jiménez de Anta, MT; Jurado, A; Marco, F; Martínez, JA; Mensa, J | 1 |
Garbino, J; Kolarova, L; Lew, D; Ondrusova, A; Rohner, P | 1 |
Kullberg, BJ; Ostrosky-Zeichner, L; Oude Lashof, AM; Rex, JH | 1 |
Denning, D; Guiver, M; Sambatakou, H | 1 |
Bliss, JM; Gigliotti, F; Wellington, M | 1 |
Gallamini, A; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Pugno, F; Viscoli, C | 1 |
Chow, E; Moore, T; Nielsen, K | 1 |
Baboor, M; Diaz, MC; Fica, A; Luppi, M; Olivares, R; Saez, L; Vasquez, P | 1 |
Boyken, L; Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
Candoni, A; Corvatta, L; D'Antonio, D; Del Favero, A; Fianchi, L; Girmenia, C; Martino, P; Nosari, A; Offidani, M; Pagano, L; Picardi, M | 1 |
Aliyeva, SE; Frising, M; Kottler, UB; Schwenn, O; Ullmann, AJ | 1 |
Rubin, ZA; Somani, J | 1 |
Cordonnier, C | 1 |
Balajee, SA; Englund, JA; Fredricks, DN; Imhof, A; Marr, KA | 1 |
Chadwick, EG; Guzman-Cottrill, JA; Zheng, X | 1 |
Breit, SM; Grand, MG; Hariprasad, SM; Mieler, WF; Mills, MD; Shah, GK | 1 |
Marr, KA | 1 |
Irving, H; Labrom, R; Nissen, M; O'Regan, P; Siebert, D; Whyte, M | 1 |
Antachopoulos, C; Bibashi, E; Dotis, J; Koliouskas, D; Papakonstantinou, E; Roilides, E; Tamiolaki, M | 1 |
Jang, GJ; Kim, KS; Lee, WK; Shin, WS | 1 |
Jagirdar, J; Scott, RS; Sutton, DA | 1 |
Allepuz-Palau, A; Alvarez-Lerma, F; Díaz-Regañón, J; García-López, F; Nicolás-Arfelis, JM; Rodríguez-Borregán, JC; Sa-Borges, M | 1 |
Bishara, J; Peled, N; Samra, Z; Yardeni, M | 1 |
Alexander, BD; Long, GD; Miller, JL; Perfect, JR; Schell, WA | 1 |
Barak, A; Bash, E; Loewenstein, A; Neudorfer, M; Siegman-Igra, Y; Zayit-Soudry, S | 1 |
Argaud, L; Martin, O; Mohammedi, I; Piens, MA; Robert, D; Thiebaut, A | 1 |
Bertz, H; Finke, J; Kern, WV; Sander, A; Wagner, D | 1 |
Chamilos, G; Kontoyiannis, DP | 1 |
Chang, SC; Chen, YC; Hsieh, SM; Lee, HT; Pan, SC | 1 |
Choti, M; Magill, SS; Merz, WG; Sears, CL; Shields, C | 1 |
Barchiesi, F; Bedini, A; Borghi, V; Codeluppi, M; Esposito, R; Guaraldi, G; Mussini, C; Rumpianesi, F; Venturelli, C | 1 |
Kyo, T; Mikami, Y; Murayama, SY; Myoken, Y; Sugata, T | 1 |
Gribskov, JL; Kirby, KA; Marr, KA; Panackal, AA; Rinaldi, M; Staab, JF | 1 |
Chen, E; Ostrosky-Zeichner, L; Paetznick, VL; Rodriguez, JR; Sims, CR | 1 |
Asada, N; Komatsu, M; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H | 1 |
Archimandritis, A; Filiotou, A; Giannaris, M; Kaloterakis, A; Mitroussia, A; Pirounaki, M; Velegraki, A | 1 |
Arechavala, A; Bianchi, MH; López Daneri, G; Negroni, R; Robles, AM; Santiso, G | 1 |
Carratalà, J; Garcia-Vidal, C | 1 |
Campbell, C; Johnson, E; Lamagni, TL; Pezzoli, L | 1 |
Aurbach, U; Cornely, O; Seifert, H; Stefanik, D | 1 |
Cheng, S; Clancy, CJ; Derendorf, H; Li, Y; Nguyen, MH | 1 |
Cantón, E; Chirivella, M; Crespo, M; Frasquet, J; Gobernado, M; Ortiz, R; Osseyran, F; Pemán, J; Pérez-Bellés, C; Quesada, A | 1 |
Blumenkranz, MS; Egbert, P; Jain, A; McCulley, TJ; Moshfeghi, DM | 1 |
Alvarez Lerma, F | 1 |
Kontoyiannis, D | 1 |
Hsueh, PR; Huang, LM; Shao, PL | 1 |
Alkorta, M; Eraso, E; Hernández-Almaraz, JL; Quindós, G; Sánchez-Vargas, LO; Villar-Vidal, M | 1 |
Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA | 1 |
Barnes, R; Colombo, A; Diekema, DJ; Finquelievich, J; Gibbs, DL; Newell, VA; Ng, KP; Pfaller, MA; Wadula, J | 1 |
Hachem, R; Raad, I | 1 |
Hoban, DJ; Karlowsky, JA; Zhanel, GG | 1 |
de Pauw, BE; Kullberg, BJ | 1 |
Coffman, S; Doern, GV; Fluit, AC; Hollis, RJ; Houston, A; Jones, RN; Messer, SA; Pfaller, MA; Sader, HS; Verhoef, J | 1 |
Chandrasekar, PH; Cutright, J; Manavathu, E | 1 |
Diekema, DJ; Fluit, AC; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA; Sader, HS | 1 |
Odds, FC; Sanglard, D | 1 |
23 review(s) available for triazoles and Fungemia
Article | Year |
---|---|
Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
Topics: Adult; Amphotericin B; Antifungal Agents; Central Venous Catheters; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mortality; Neutropenia; Triazoles; Trichosporon; Trichosporonosis; Voriconazole | 2020 |
Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia.
Topics: Amphotericin B; Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Endophthalmitis; Female; Fungemia; Fusariosis; Fusarium; Humans; Immunocompromised Host; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2018 |
Second- versus first-generation azoles for antifungal prophylaxis in hematology patients: a systematic review and meta-analysis.
Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Multicenter Studies as Topic; Mycoses; Neutropenia; Odds Ratio; Patient Dropouts; Prospective Studies; Randomized Controlled Trials as Topic; Transplantation Conditioning; Treatment Outcome; Triazoles | 2013 |
Rhinocerebral zygomycosis with pansinusitis in a 14-year-old girl with type 1 diabetes: a case report and review of the literature.
Topics: Adolescent; Antifungal Agents; Blindness; Diabetes Mellitus, Type 1; Disease Progression; Electromyography; Female; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Meningitis, Fungal; Nose Diseases; Opportunistic Infections; Rare Diseases; Risk Assessment; Severity of Illness Index; Treatment Outcome; Triazoles; Zygomycosis | 2013 |
Posaconazole: promising but problematic in practice in pediatric patients.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Fungemia; Humans; Infant; Infant, Newborn; Male; Treatment Outcome; Triazoles | 2015 |
Trichosporon mucoides fungemia in a liver transplant recipient: case report and review.
Topics: Antifungal Agents; Enterococcus faecium; Fatal Outcome; Fungemia; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Mycoses; Peritonitis; Postoperative Complications; Tacrolimus; Triazoles; Trichosporon; Vancomycin; Vancomycin Resistance | 2009 |
[Advances in the diagnosis and treatment of yeast infections: role of the new antifungal agents].
Topics: Amphotericin B; Antibodies, Fungal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Fungal; Candida; Candidiasis; Clinical Trials as Topic; DNA, Fungal; Drug Interactions; Echinocandins; Fungemia; Humans; Mycology; Mycoses; Triazoles; Yeasts | 2008 |
Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Aspergillus; DNA, Fungal; Female; Fungemia; Humans; Immunocompromised Host; Incidence; Male; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Risk Assessment; Severity of Illness Index; Survival Rate; Triazoles; Voriconazole | 2010 |
The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review.
Topics: Aged; Antifungal Agents; Diabetes Mellitus, Type 2; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Risk Factors; Saccharomycetales; Treatment Outcome; Triazoles; Voriconazole | 2010 |
[Combination therapy for invasive aspergillosis].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Echinocandins; Forecasting; Fungemia; Guinea Pigs; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Meningitis, Fungal; Micafungin; Mice; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Retrospective Studies; Triazoles | 2011 |
Rhodotorula fungemia: two cases and a brief review.
Topics: Amphotericin B; Antifungal Agents; Catheterization, Central Venous; Female; Fungemia; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Pyrimidines; Rhodotorula; Treatment Outcome; Triazoles; Voriconazole; Wounds and Injuries | 2011 |
Antifungal pharmacotherapy for neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Mucormycosis in hematologic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Encephalitis; Female; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Italy; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Retrospective Studies; Risk Factors; Sinusitis; Treatment Outcome; Triazoles | 2004 |
New options for the treatment of invasive fungal infections.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycetoma; Mycoses; Neoplasms; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2004 |
Fungal infections: current diagnosis and treatment.
Topics: Amphotericin B; Antifungal Agents; Fungemia; Humans; Immunocompromised Host; Mycoses; Neoplasms; Neutropenia; Premedication; Randomized Controlled Trials as Topic; Risk Factors; Triazoles | 2004 |
Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Endocarditis; Female; Follow-Up Studies; Fungemia; Fusarium; Humans; Immunocompromised Host; Infant; Leukemia, Myeloid, Acute; Liposomes; Opportunistic Infections; Pyrimidines; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Invasive Candida infections: the changing epidemiology.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Flucytosine; Fungemia; Humans; Incidence; Prevalence; Risk Factors; Triazoles; United States | 2004 |
[Native valve Aspergillus fumigatus endocarditis with blood culture positive and negative for galactomannan antigen. Case report and literature review].
Topics: Amaurosis Fugax; Aneurysm, Infected; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Biomarkers; Caspofungin; Combined Modality Therapy; Echinocandins; Endocarditis; False Negative Reactions; Fatal Outcome; Fungemia; Galactose; Heart Valve Prosthesis Implantation; Humans; Infarction; Kidney; Lipopeptides; Male; Mannans; Mesenteric Arteries; Mesenteric Vascular Occlusion; Middle Aged; Mitral Valve; Peptides, Cyclic; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Renal Artery; Triazoles; Voriconazole | 2007 |
[Role of voriconazole in critically ill patients with invasive mycoses].
Topics: Antifungal Agents; Comorbidity; Critical Care; Fungemia; Humans; Intensive Care Units; Kidney; Multicenter Studies as Topic; Mycoses; Prospective Studies; Pyrimidines; Spain; Triazoles; Voriconazole | 2007 |
[Addressing the "Hot Spots" in the management of invasive aspergillosis].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Disease Management; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Treatment Outcome; Triazoles | 2007 |
Recent advances and challenges in the treatment of invasive fungal infections.
Topics: Antifungal Agents; Aspergillus; Candida; Double-Blind Method; Echinocandins; Fungemia; Fungi; Humans; Mycoses; Randomized Controlled Trials as Topic; Triazoles | 2007 |
Therapy of invasive fungal infections.
Topics: Amphotericin B; Antifungal Agents; Catheterization, Central Venous; Contraindications; Drug Therapy, Combination; Flucytosine; Fungemia; Granulocyte Colony-Stimulating Factor; Humans; Immunotherapy; Mycoses; Neutropenia; Triazoles | 1999 |
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Oxidoreductases; Sterol 14-Demethylase; Triazoles | 2002 |
4 trial(s) available for triazoles and Fungemia
Article | Year |
---|---|
No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year "real-life" evaluation.
Topics: Adult; Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Laboratory Techniques; Female; Fluconazole; Fungemia; Germany; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Prospective Studies; Triazoles; Young Adult | 2014 |
Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemoprevention; Female; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Plasma; Survival Analysis; Tablets; Triazoles; Young Adult | 2016 |
Clinical use and tolerability of voriconazole in the treatment of fungal infections in critically ill patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Fungemia; Humans; Intensive Care Units; Logistic Models; Male; Maximum Tolerated Dose; Middle Aged; Probability; Prospective Studies; Pyrimidines; Risk Assessment; Single-Blind Method; Statistics, Nonparametric; Survival Rate; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2008 |
89 other study(ies) available for triazoles and Fungemia
Article | Year |
---|---|
First fungemia case due to environmental yeast Wickerhamomyces myanmarensis: detection by multiplex qPCR and antifungal susceptibility.
Topics: Antifungal Agents; Child; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Male; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; Saccharomycetales; Triazoles; Voriconazole | 2019 |
Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Candidiasis, Invasive; Child; Child, Preschool; Combined Modality Therapy; Cross Infection; Drug Evaluation; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Postoperative Complications; Retrospective Studies; Risk; Transplantation, Homologous; Treatment Outcome; Triazoles; Young Adult | 2013 |
Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Topics: Amphotericin B; Antifungal Agents; Candidiasis, Invasive; Catheter-Related Infections; Chemotherapy-Induced Febrile Neutropenia; Clinical Trials as Topic; Combined Modality Therapy; Drug Monitoring; Drug Therapy, Combination; Echinocandins; Fungemia; Humans; Immunocompromised Host; Immunotherapy; Invasive Pulmonary Aspergillosis; Mycoses; Neoplasms; Salvage Therapy; Triazoles | 2014 |
Scedosporium prolificans fungaemia in a patient with acute lymphoblastic leukaemia.
Topics: Allografts; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Drug Substitution; Fatal Outcome; Female; Fluconazole; Fungemia; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Scedosporium; Triazoles; Voriconazole; Young Adult | 2013 |
[Three cases of fungemia caused by Blastoschizomyces capitatus].
Topics: Adult; Amphotericin B; Antifungal Agents; Caspofungin; Child; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Lymphoma, B-Cell; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Saccharomycetales; Triazoles; Voriconazole; Young Adult | 2013 |
Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fungemia; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole | 2014 |
Malassezia pachydermatis fungaemia in an adult on posaconazole prophylaxis for acute myeloid leukaemia.
Topics: Aged; Antifungal Agents; Fungemia; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Malassezia; Male; Mycoses; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Superinfection; Triazoles | 2014 |
Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Fungemia; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Romania; Saccharomyces cerevisiae; Triazoles; Voriconazole; Yeasts; Young Adult | 2015 |
Serum posaconazole levels during acute myeloid leukaemia induction therapy: correlations with breakthrough invasive fungal infections.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Agents; Fungemia; Humans; Incidence; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Serum; Triazoles; Young Adult | 2015 |
Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.
Topics: Administration, Oral; Adult; Aged; Allografts; Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Cause of Death; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Incidence; Lipopeptides; Male; Medication Adherence; Middle Aged; Mycoses; Neutropenia; Patient Compliance; Premedication; Retrospective Studies; Risk Assessment; Risk Factors; Survival Analysis; Transplantation Conditioning; Treatment Failure; Triazoles; Young Adult | 2015 |
[Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Topics: Antifungal Agents; Candida; Candidiasis, Invasive; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Intensive Care Units; Itraconazole; Microbial Sensitivity Tests; Species Specificity; Triazoles; Turkey; Voriconazole | 2016 |
Comparison of posaconazole and voriconazole in vitro killing against Candida krusei.
Topics: Antifungal Agents; Candida; Candidiasis; Culture Media; Drug Resistance, Fungal; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2008 |
Disseminated Saksenaea vasiformis in an immunocompetent host.
Topics: Amphotericin B; Antifungal Agents; Child; Fungemia; Humans; Immunocompetence; Male; Mucorales; Mucormycosis; Plastic Surgery Procedures; Surgical Flaps; Triazoles | 2008 |
Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cross Infection; Dermatomycoses; Drug Resistance, Fungal; Echinocandins; Female; Flucytosine; Fungemia; Hospitals, University; Humans; Mycological Typing Techniques; Mycoses; Onychomycosis; Opportunistic Infections; Organ Specificity; Triazoles; Trichosporon; Urine; Vaginitis | 2008 |
Voriconazole and posaconazole resistant Candida pelliculosa fungemia after cardiac surgery.
Topics: Amphotericin B; Antifungal Agents; Candida; Cardiac Surgical Procedures; Child; Drug Resistance, Multiple, Fungal; Fungemia; Humans; Infant; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole | 2009 |
Early detection of breakthrough trichosporonosis by serum PCR in a cord blood transplant recipient being prophylactically treated with voriconazole.
Topics: Adolescent; Antifungal Agents; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; DNA, Fungal; Fungemia; Humans; Male; Mycoses; Myelodysplastic Syndromes; Polymerase Chain Reaction; Prognosis; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2008 |
Triazole-resistant candidaemia following posaconazole exposure.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fungemia; Humans; Male; Microbial Sensitivity Tests; Triazoles; Young Adult | 2009 |
Recent experience with fungaemia: change in species distribution and azole resistance.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Child; Drug Resistance, Fungal; Fungemia; Humans; India; Risk Factors; Treatment Outcome; Triazoles | 2009 |
Successful treatment with voriconazole of prolonged Paecilomyces lilacinus fungemia in a chronic hemodialyzed patient.
Topics: Aged; Antifungal Agents; Catheter-Related Infections; Catheters, Indwelling; Female; Fungemia; Humans; Paecilomyces; Pyrimidines; Renal Dialysis; Triazoles; Voriconazole | 2009 |
Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida; Candidiasis; Caspofungin; Catheter-Related Infections; Cross Infection; Echinocandins; Fungemia; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2009 |
Subcutaneous mycosis and fungemia by Aureobasidium pullulans: a rare pathogenic fungus in a post allogeneic BM transplant patient.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Fungemia; Humans; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2010 |
Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Caspofungin; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungemia; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycological Typing Techniques; Polyenes; Population Surveillance; Prevalence; Triazoles | 2010 |
A novel fungal pathogen under the spotlight--Acremonium spp. associated fungaemia in an immunocompetent host.
Topics: Acremonium; Antifungal Agents; Female; Fungemia; Humans; Immunocompromised Host; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2011 |
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Fungemia; Itraconazole; Laboratories, Hospital; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole; Yeasts | 2010 |
In vitro activity of antifungal combinations against Candida albicans biofilms.
Topics: Amphotericin B; Antifungal Agents; Austria; Biofilms; Candida albicans; Candidiasis; Caspofungin; Drug Synergism; Echinocandins; Fungemia; Humans; Intensive Care Units; Lipopeptides; Microbial Sensitivity Tests; Triazoles | 2010 |
Candida spp. bloodstream infection: influence of antifungal treatment on outcome.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Humans; Male; Middle Aged; Survival Analysis; Treatment Outcome; Triazoles | 2010 |
Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida tropicalis; Candidiasis; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Fungemia; Humans; Infant; Lipopeptides; Male; Micafungin; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2010 |
Acremonium strictum fungaemia in a paediatric immunocompromised patient: diagnosis and treatment difficulties.
Topics: Acremonium; Amphotericin B; Antifungal Agents; Blood; Child; Fever; Fungemia; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2010 |
New onset of bilateral multifocal coccidioidomycosal choroiditis in a patient on oral fluconazole.
Topics: Administration, Oral; Antifungal Agents; Choroiditis; Coccidioides; Coccidioidomycosis; Eye Infections, Fungal; Fluconazole; Functional Laterality; Fungemia; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Visual Acuity; Voriconazole | 2010 |
[Rhodotorula glutinis sepsis. A case report].
Topics: Aged; Antifungal Agents; Catheter-Related Infections; Catheterization, Central Venous; Communicable Diseases, Emerging; Comorbidity; Diabetes Complications; Fungemia; Humans; Immunocompromised Host; Liver Cirrhosis; Male; Mycoses; Pyrimidines; Rhodotorula; Sepsis; Triazoles; Voriconazole | 2010 |
Fatal invasive trichosporonosis due to Trichosporon loubieri in a patient with T-lymphoblastic lymphoma.
Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Fatal Outcome; Female; Fungemia; Humans; Immunocompromised Host; Molecular Sequence Data; Mycoses; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole; Young Adult | 2011 |
Invasive fungal rhinitis caused by Paecilomyces lilacinus infection: Report of a case and a novel treatment.
Topics: Aged; Antifungal Agents; Combined Modality Therapy; Debridement; Female; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Lung Transplantation; Mycoses; Paecilomyces; Pulmonary Fibrosis; Pyrimidines; Rhinitis; Severity of Illness Index; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis.
Topics: Adult; Antifungal Agents; Ascomycota; Caspofungin; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Fungemia; Heart Transplantation; Histocytochemistry; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Male; Microscopy; Molecular Sequence Data; Mycoses; Pleura; Pyrimidines; Radiography, Thoracic; Sequence Analysis, DNA; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Comparative in vitro activities of fluconazole, voriconazole, and MXP-4509 against Romanian blood yeast isolates.
Topics: Antifungal Agents; Blood; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Romania; Triazoles; Voriconazole; Yeasts | 2011 |
Recurrent Saccharomyces cerevisiae fungemia in an otherwise healthy patient.
Topics: Abdominal Pain; Adult; Amphotericin B; Antifungal Agents; Chills; Diagnosis, Differential; Female; Fever; Fluconazole; Flucytosine; Fungemia; Headache; Humans; Nausea; Pyrimidines; Recurrence; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2011 |
Breakthrough fungemia due to Candida glabrata during posaconazole prophylaxis in hematology patients treated with anidulafungin - report of 5 cases.
Topics: Adult; Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Leukemia; Male; Middle Aged; Slovakia; Treatment Outcome; Triazoles | 2011 |
Fusarium verticillioides fungemia in a liver transplantation patient: successful treatment with voriconazole.
Topics: Adult; Antifungal Agents; Female; Fungemia; Fusariosis; Fusarium; Humans; Immunocompromised Host; Liver Transplantation; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Drug Therapy, Combination; Fatal Outcome; Fungemia; Humans; Leukemia, Myeloid, Acute; Male; Pyrimidines; Triazoles; Trichosporon; Trichosporonosis; Voriconazole; Young Adult | 2012 |
Ambroxol influences voriconazole resistance of Candida parapsilosis biofilm.
Topics: Ambroxol; Antifungal Agents; Biofilms; Candida; Colorimetry; Drug Synergism; Fungemia; Humans; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Tetrazolium Salts; Triazoles; Voriconazole | 2012 |
Posaconazole as successful treatment for fungemia due to Cryptococcus albidus in a liver transplant recipient.
Topics: Antifungal Agents; Cryptococcosis; Fungemia; Humans; Liver Transplantation; Male; Middle Aged; Opportunistic Infections; Triazoles | 2013 |
[Fungal infection secondary to treatment of Escherichia coli in a critically ill patient].
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Aspergillus; Candida; Candidiasis; Caspofungin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Echinocandins; Escherichia coli; Fungemia; Humans; Lipopeptides; Male; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2012 |
Invasive mucormycosis in an immunocompetent patient with allergic fungal rhinosinusitis.
Topics: Antifungal Agents; Biopsy, Needle; Endoscopy; Follow-Up Studies; Fungemia; Humans; Immunocompetence; Immunohistochemistry; Male; Middle Aged; Mucorales; Mucormycosis; Rhinitis, Allergic, Perennial; Risk Assessment; Sinusitis; Treatment Outcome; Triazoles | 2013 |
[Disseminated infection due to Geotrichum capitatum].
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Fungemia; Geotrichosis; Geotrichum; Granuloma; Hepatitis; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Lipopeptides; Male; Neutropenia; Opportunistic Infections; Sepsis; Triazoles | 2012 |
Successful treatment of Candida glabrata myocarditis with voriconazole.
Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography, Transesophageal; Follow-Up Studies; Fungemia; Humans; Male; Myocarditis; Pyrimidines; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2002 |
Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Drug Synergism; Drug Therapy, Combination; Female; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Middle Aged; Multiple Myeloma; Mycetoma; Naphthalenes; Opportunistic Infections; Pyrimidines; Risk Assessment; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole.
Topics: Agar; Antifungal Agents; Candida glabrata; Candidiasis; Culture Media; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Triazoles; Voriconazole | 2003 |
Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001).
Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Spain; Triazoles; Voriconazole | 2003 |
Successful treatment of pulmonary invasive aspergillosis with voriconazole in patients who failed conventional therapy.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Fungal; Follow-Up Studies; Fungemia; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Sampling Studies; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Voriconazole salvage treatment of invasive candidiasis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Cohort Studies; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Fungemia; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Risk Assessment; Salvage Therapy; Severity of Illness Index; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Pulmonary aspergillosis in a patient with chronic granulomatous disease: confirmation by polymerase chain reaction and serological tests, and successful treatment with voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Fungemia; Granulomatous Disease, Chronic; Humans; Lung Diseases, Fungal; Male; Polymerase Chain Reaction; Pyrimidines; Sensitivity and Specificity; Serologic Tests; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Successful treatment of Acremonium fungemia with voriconazole.
Topics: Acremonium; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Female; Fungemia; Humans; Lymphoma, Mantle-Cell; Middle Aged; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2003 |
Case report: Invasive aspergillosis successfully treated with voriconazole without recurrence during subsequent bone marrow transplantation.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Unsuccessful treatment with voriconazole of a brain abscess due to Cladophialophora bantiana.
Topics: Aged; Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Cladosporium; Combined Modality Therapy; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatal Outcome; Fungemia; Humans; Male; Pyrimidines; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Failure; Triazoles; Voriconazole | 2003 |
In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2004 |
Histological examination of an eye with endogenous Aspergillus endophthalmitis treated with oral voriconazole: a case report.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Fungemia; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2004 |
Pfizer's Vfend as effective in treating candidemia as two-drug standard of care according to study.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Pyrimidines; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.
Topics: Adult; Aspergillosis; Aspergillus; Candida glabrata; Candidiasis; Child; Drug Resistance, Fungal; Female; Fungemia; Fungi; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis | 2004 |
Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Aqueous Humor; Biological Availability; Candidiasis; Caspofungin; Chromatography, High Pressure Liquid; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Female; Fungemia; Humans; Infusions, Intravenous; Injections; Lipopeptides; Male; Middle Aged; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Triazoles; Vitreous Body; Voriconazole | 2005 |
Disseminated Scedosporium prolificans infection and survival of a child with acute lymphoblastic leukemia.
Topics: Antifungal Agents; Child; Female; Fungemia; Humans; Immunocompromised Host; Mycetoma; Naphthalenes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Fungemia; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Trichosporon; Voriconazole | 2005 |
Treatment of candida chorioretinitis with voriconazole.
Topics: Antifungal Agents; Candidiasis; Chorioretinitis; Eye Infections, Fungal; Female; Fungemia; Humans; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2005 |
Lung infection due to opportunistic fungus, Phialemonium obovatum, in a bone marrow transplant recipient: an emerging infection with fungemia and Crohn disease-like involvement of the gastrointestinal tract.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Bone Marrow Transplantation; Drug Resistance, Fungal; Fungemia; Gastrointestinal Diseases; Graft vs Host Disease; Granuloma; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2005 |
Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
Topics: Academic Medical Centers; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Israel; Itraconazole; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2005 |
Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole.
Topics: Adolescent; Adult; Candida glabrata; Female; Fluconazole; Fungemia; Humans; Leukemia; Male; Microbial Sensitivity Tests; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole | 2005 |
Endogenous Phialemonium curvatum endophthalmitis.
Topics: Aged; Antifungal Agents; Ascomycota; Cataract Extraction; Drug Contamination; Endocarditis; Endophthalmitis; Erectile Dysfunction; Eye Infections, Fungal; Fungemia; Humans; Male; Muscle, Smooth; Mycoses; Parasympatholytics; Pyrimidines; Triazoles; Ultrasonography; Vitrectomy; Vitreous Body; Voriconazole | 2005 |
Emergence of Candida albicans fungemia during voriconazole therapy.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fatal Outcome; Female; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2005 |
Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis.
Topics: Aged; Amphotericin B; Anemia, Aplastic; Ascomycota; Aspergillosis; Body Fluids; Caspofungin; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Mycoses; Peptides, Cyclic; Pyrimidines; Saccharomycetales; Shock, Septic; Triazoles; Voriconazole | 2005 |
Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Fungemia; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycoses; Neutropenia; Paecilomyces; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Septic Candida krusei thrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Intensive Care Units; Lipopeptides; Peptides, Cyclic; Pyrimidines; Thrombophlebitis; Triazoles; Vena Cava, Inferior; Voriconazole | 2005 |
Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy.
Topics: Antifungal Agents; Blood; Candida; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fatal Outcome; Female; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Middle Aged; Triazoles | 2006 |
Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Cross Infection; Drug Resistance, Fungal; Female; Fungemia; Hospitals, University; Humans; Infant; Infant, Newborn; Italy; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Triazoles | 2006 |
Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies.
Topics: Candida albicans; Candidiasis; Drug Resistance; Fluconazole; Fungemia; Hematologic Neoplasms; Humans; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2006 |
Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.
Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis; Child; Drug Resistance, Fungal; Fluconazole; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2006 |
Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fungemia; Humans; Microbial Sensitivity Tests; Triazoles | 2006 |
Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Echinocandins; Fungemia; Humans; Leukemia, Myeloid; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2006 |
First case of Penicillium marneffei fungemia in Greece and strain susceptibility to five licensed systemic antifungal agents and posaconazole.
Topics: Antifungal Agents; Drug Resistance, Bacterial; Fungemia; Greece; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillium; Triazoles | 2006 |
[Clinical cases in medical mycology. Case no. 21].
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Endophthalmitis; Exophiala; Female; Fungemia; Humans; Itraconazole; Middle Aged; Mycoses; Opportunistic Infections; Osteolysis; Pregnancy; Pregnancy Complications, Infectious; Pyrimidines; Recurrence; Th2 Cells; Triazoles; Voriconazole | 2006 |
Echinocandins for candidemia.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Fungemia; Humans; Pyrimidines; Triazoles; Voriconazole | 2006 |
Unexplained increase in Paecilomyces variotii blood culture isolates in the UK.
Topics: Amphotericin B; Antifungal Agents; Blood; Caspofungin; Diagnosis, Differential; Echinocandins; Equipment Contamination; False Positive Reactions; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Paecilomyces; Peptides, Cyclic; Pyrimidines; Species Specificity; Triazoles; United Kingdom; Voriconazole | 2006 |
In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
Topics: Antifungal Agents; Area Under Curve; Candida; Fungemia; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2007 |
Measurement of voriconazole activity against Candida albicans, C. glabrata, and C. parapsilosis isolates using time-kill methods validated by high-performance liquid chromatography.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Chromatography, High Pressure Liquid; Culture Media; Dose-Response Relationship, Drug; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2007 |
Endogenous Scedosporium apiospermum endophthalmitis.
Topics: Adult; Antifungal Agents; Aqueous Humor; Biological Availability; Endophthalmitis; Eye Infections, Fungal; Fatal Outcome; Female; Fungemia; Humans; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Triazoles; Vitreous Body; Voriconazole | 2007 |
Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Hospitals; Humans; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole | 2008 |
Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.
Topics: Africa; Antifungal Agents; Asia; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Europe; Fluconazole; Fungemia; Global Health; Humans; Latin America; Microbial Sensitivity Tests; Middle East; North America; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2008 |
Treatment of central venous catheter-related fungemia due to Fusarium oxysporum.
Topics: Catheterization, Central Venous; Fever; Fungemia; Fusarium; Humans; Male; Middle Aged; Neutropenia; Triazoles | 1995 |
In vitro susceptibilities of Candida and Cryptococcus neoformans isolates from blood cultures of neutropenic patients.
Topics: Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 1999 |
International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europ
Topics: Antifungal Agents; Candida; Candidiasis; Europe; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Triazoles | 1999 |
Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Fungemia; Guinea Pigs; Humans; Lung Diseases, Fungal; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2000 |
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surv
Topics: Antifungal Agents; Candida; Candidiasis; Europe; Fluconazole; Fungemia; Humans; Latin America; North America; Pyrimidines; Sentinel Surveillance; Thiazoles; Triazoles; Voriconazole | 2001 |